Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
October 28, 2019 at 04:08 am EDT
Share
Jiangxi Synergy Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 281.253 million compared to CNY 187.395 million a year ago. Operating income was CNY 46.604 million compared to CNY 28.409 million a year ago. Net income was CNY 41.881 million compared to CNY 26.217 million a year ago. Basic earnings per share from continuing operations was CNY 0.521 compared to CNY 0.3277 a year ago. Diluted earnings per share from continuing operations was CNY 0.521 compared to CNY 0.3274 a year ago.
Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. 
